Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Depreciation and Depletion (2017 - 2019)

Arrowhead Pharmaceuticals' Depreciation and Depletion history spans 3 years, with the latest figure at $578342.0 for Q2 2019.

For Q2 2019, Depreciation and Depletion fell 23.0% year-over-year to $578342.0; the TTM value through Jun 2019 reached $2.8 million, changed N/A, while the annual FY2018 figure was $3.0 million, 0.3% changed from the prior year.
Depreciation and Depletion reached $578342.0 in Q2 2019 per ARWR's latest filing, down from $750860.0 in the prior quarter.
In the past five years, Depreciation and Depletion ranged from a high of $752245.0 in Q4 2018 to a low of $578342.0 in Q2 2019.
Average Depreciation and Depletion over 3 years is $712834.3, with a median of $739609.5 recorded in 2018.
Peak YoY movement for Depreciation and Depletion: rose 5.05% in 2018, then fell 23.0% in 2019.
A 3-year view of Depreciation and Depletion shows it stood at $716066.0 in 2017, then rose by 5.05% to $752245.0 in 2018, then dropped by 23.12% to $578342.0 in 2019.
Per Business Quant, the three most recent readings for ARWR's Depreciation and Depletion are $578342.0 (Q2 2019), $750860.0 (Q1 2019), and $752245.0 (Q4 2018).